LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.10 | 771.67 | 2418 | 9800 | 0.2467 | 0.3655 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 67.10 | 771.67 | 2164 | 9800 | 0.2208 | 0.3247 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.32 | 771.67 | 2475 | 10212 | 0.2424 | 0.3672 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 69.32 | 771.67 | 2224 | 10212 | 0.2178 | 0.3285 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 71.54 | 771.67 | 2586 | 10532 | 0.2455 | 0.3781 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 71.54 | 771.67 | 2247 | 10532 | 0.2133 | 0.3277 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 73.76 | 771.67 | 2673 | 10851 | 0.2463 | 0.3851 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 73.76 | 771.67 | 2324 | 10851 | 0.2142 | 0.3352 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.02 | 771.67 | 2757 | 11106 | 0.2482 | 0.3923 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 76.02 | 771.67 | 2417 | 11106 | 0.2176 | 0.3455 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.25 | 771.67 | 2840 | 11367 | 0.2498 | 0.3990 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 78.25 | 771.67 | 2426 | 11367 | 0.2134 | 0.3433 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.48 | 771.67 | 2924 | 11685 | 0.2502 | 0.4047 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 80.48 | 771.67 | 2456 | 11685 | 0.2102 | 0.3435 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.69 | 771.67 | 3017 | 11974 | 0.2520 | 0.4115 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 82.69 | 771.67 | 2545 | 11974 | 0.2125 | 0.3521 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.92 | 771.67 | 3117 | 12266 | 0.2541 | 0.4188 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 84.92 | 771.67 | 2583 | 12266 | 0.2106 | 0.3536 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 87.14 | 771.67 | 3190 | 12592 | 0.2533 | 0.4223 | MN20160304_L01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 87.14 | 771.67 | 2675 | 12592 | 0.2124 | 0.3615 | MN20160304_L01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 2.49 | 771.67 | 768 | 867 | 0.8851 | -0.0278 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 2.49 | 771.67 | 902 | 867 | 1.0395 | 1.5138 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 4.71 | 771.67 | 870 | 956 | 0.9097 | 0.4732 | MN20160304_L01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 4.71 | 771.67 | 1018 | 956 | 1.0644 | 1.4470 | MN20160304_L01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 6.94 | 771.67 | 932 | 1045 | 0.8918 | 0.5394 | MN20160304_L01 | D07 |